CBLL CeriBell Q4 loss narrows more than expected EPS surprise of 144 sends shares up 114 CoStar CSGP Volume Analysis Q4 2025 EPS Exceeds Expectations PEP PepsiCo notches 28 percent Q1 2026 EPS beat but stock falls 064 percent on mixed investor sentiment The real story behind CareDx CDNA earnings numbers Q1 2026 Better Than Expected ORIC Q1 2026 Earnings NarrowerThanExpected Loss Pipeline Progress Keeps Focus on Key Milestones QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue Rapport Therapeutics Inc RAPP Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain ICHR Q1 2026 Earnings EPS Beat Surprises Revenue Details Omitted LITS Q4 2024 Earnings Significant EPS Miss Raises Concerns Amid Lack of Revenue Disclosure CIMN Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Market Reaction Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges NFG Q1 2026 Earnings Earnings Miss Estimates Amid Slight Stock Decline SRRK Q1 2026 Earnings Narrowed EPS Miss and Steady Pipeline Progress Amid No Revenue PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment RRC Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency NanoX Imaging Ltd NNOX Q4 2025 Earnings Significant EPS Miss Amid Ongoing Commercialization Efforts